Should transcobalamin deficiency be treated aggressively?

Area of Science:

• Genetics
• Biochemistry
• Pediatrics

Background:

• Transcobalamin (TC) is essential for cellular uptake of vitamin B12 (cobalamin, Cbl).
• TC deficiency is a rare autosomal recessive disorder leading to intracellular Cbl depletion.
• This depletion causes megaloblastic bone marrow failure and metabolic derangements.

Observation:

• Five patients with TC deficiency were studied.
• Early and adequate treatment led to favorable outcomes.
• Inadequate treatment resulted in late-onset severe neuro-ophthalmological impairment.

Findings:

• Six novel mutations in the TCN2 gene were identified.
• These mutations disrupt critical Cbl-TC and TC-receptor binding domains.
• Clinical presentation includes failure to thrive, pancytopenia, megaloblastic anemia, and potential neurological issues.

Implications:

• TC deficiency is a severe condition requiring early diagnosis and aggressive, long-term management.
• Timely intervention can prevent severe, irreversible neurological damage.
• Understanding mutation impacts aids in predicting disease severity and guiding therapy.